CD137 on inflamed lymphatic endothelial cells enhances CCL21-guided migration of dendritic cells

FASEB Journal

Volumn 26, Issue 8, 2012, Pages 3380-3392

  Teijeira, Álvaro ^a   Palazón, Asís ^a   Garasa, Saray ^a   Marré, Diego ^a   Aubá, Cristina ^a   Rogel, Anne ^b   Murillo, Ohiana ^a   Martínez Forero, Iván ^a   Lang, François ^b   Melero, Ignacio ^a   Rouzaut, Ana ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b UNIVERSITÉ DE NANTES   (France)

Author keywords

Antigen presenting cells; TNF receptor family; Transmigration through lymphatic capillaries

Indexed keywords

CD11B ANTIGEN; CD137 ANTIGEN; CD137 LIGAND; CHEMOKINE RECEPTOR CCR7; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MESSENGER RNA; MONOCLONAL ANTIBODY; SECONDARY LYMPHOID TISSUE CHEMOKINE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4;

ANTIGEN EXPRESSION; ARTICLE; ATHEROSCLEROSIS; CAPILLARY; CELL ACTIVATION; CELL HYPOXIA; CELL MIGRATION; CONTROLLED STUDY; CROSS LINKING; CYTOKINE PRODUCTION; DENDRITIC CELL; DERMIS; EX VIVO STUDY; EXPLANT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; INFLAMMATION; LEUKOCYTE; LYMPH VESSEL ENDOTHELIUM; LYMPHATIC ENDOTHELIUM CELL; MONOCYTE; MONOLAYER CULTURE; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD137; CELL MOVEMENT; CHEMOKINE CCL21; DENDRITIC CELLS; DERMATITIS; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; LYMPHATIC VESSELS; NF-KAPPA B; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84864772197     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.11-201061     Document Type: Article

References (49)

1. Melero, I., Murillo, O., Dubrot, J., Hervs-Stubbs, S., and Perez-Gracia, J. (2008) Multi-layered action mechanisms of CD137 (4-1BB)-targeted immunotherapies. Trends Pharmacol. Sci 29, 383-390
2. Melero, I., Johnston, J. V., Shufford, W. W., Mittler, R. S., and Chen, L. (1998) NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies. Cell. Immunol. 190, 167-172 (Pubitemid 29011104)
3. Kwon, B. S., and Weissman, S. M. (1989) cDNA sequences of two inducible T-cell genes. Proc. Natl. Acad. Sci. U. S. A. 86, 1963-1967 (Pubitemid 19087048)
4. Armitage, R. J. (1994) Tumor necrosis factor receptor superfamily members and their ligands. Curr. Opin. Immunol. 6, 407-413
5. Kwon, B., Kim, B., Cho, H., Park, J., and Kwon, B. (2003) Involvement of tumor necrosis factor receptor superfamily (TNFRSF) members in the pathogenesis of inflammatory diseases. Exp. Mol. Med. 35, 8-16 (Pubitemid 36336923)
6. Choi, B., Kim, Y., Kim, C., Kim, M., Kim, K., Oh, H., Lee, M., Lee, D., Vinay, D., and Kwon, B. (2010) Peripheral 4-1BB signaling negatively regulates NK cell development through IFN-gamma. J. Immunol. 185, 1404-1411
7. Watts, T. (2005) TNF/TNFR family members in costimulation of T cell responses. Ann. Rev. Immunol. 23, 23-68
8. Wen, T., Bukczynski, J., and Watts, T. (2002) 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function. J. Immunol. 168, 4897-4906 (Pubitemid 34495951)
9. Shao, Z., and Schwarz, H. (2011) CD137 ligand, a member of the tumor necrosis factor family, regulates immune responses via reverse signal transduction. J. Leukocyte Biol. 89, 21-29
10. Laderach, D., Wesa, A., and Galy, A. (2003) 4-1BB-ligand is regulated on human dendritic cells and induces the production of IL-12. Cell. Immunol. 226, 37-44 (Pubitemid 38121296)
11. Kim, Y., Li, G., and Broxmeyer, H. (2002) 4-1BB ligand stimulation enhances myeloid dendritic cell maturation from human umbilical cord blood CD34 progenitor cells. J. Hematother. Stem Cell Res. 11, 895-903 (Pubitemid 36139770)
12. Melero, I., Shuford, W. W., Newby, S. A., Aruffo, A., Ledbetter, J. A., Hellstrm, K. E., Mittler, R. S., and Chen, L. (1997) Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nat. Med. 3, 682-685 (Pubitemid 27264981)
13. Lynch, D. (2008) The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer. Immunol. Rev. 222, 277-286
14. Lee, S., Salek-Ardakani, S., Mittler, R., and Croft, M. (2009) Hypercostimulation through 4-1BB distorts homeostasis of immune cells. J. Immunol. 182, 6753-6762
15. Dubrot, J., Milheiro, F., Alfaro, C., Palazn, A., Martinez-Forero, I., Perez-Gracia, J., Morales-Kastresana, A., Romero-Trevejo, J., Ochoa, M., Hervs-Stubbs, S., Prieto, J., Jure-Kunkel, M., Chen, L., and Melero, I. (2010) Treatment with anti-CD137 mAbs causes intense accumulations of liver T cells without selective antitumor immunotherapeutic effects in this organ. Cancer Immunol. Immunother. 59, 1223-1233
16. von Kempis, J., Schwarz, H., and Lotz, M. (1997) Differentiation- dependent and stimulus-specific expression of ILA, the human 4-1BB-homologue, in cells of mesenchymal origin. Osteoarthritis Cartilage 5, 394-406 (Pubitemid 27522759)
17. Wan, Y., Zheng, S., Zhao, Z., Li, M., Jia, C., and Zhang, H. (2004) Expression of co-stimulator 4-1BB molecule in hepatocellular carcinoma and adjacent non-tumor liver tissue, and its possible role in tumor immunity. World J. Gastroenterol. 10, 195-199 (Pubitemid 38195260)
18. Salih, H. R., Kosowski, S. G., Haluska, V. F., Starling, G. C., Loo, D. T., Lee, F., Aruffo, A. A., Trail, P. A., and Kiener, P. A. (2000) Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cells. J. Immunol. 165, 2903-2910 (Pubitemid 30660743)
19. Broll, K., Richter, G., Pauly, S., Hofstaedter, F., and Schwarz, H. (2001) CD137 expression in tumor vessel walls. high correlation with malignant tumors. Am. J. Clin. Pathol. 115, 543-549 (Pubitemid 32275946)
20. Palazon, A., Teijeira, A., Martnez-Forero, I., Hervs-Stubbs, S., Roncal, C., Peuelas, I., Dubrot, J., Morales-Kastresana, A., Prez-Gracia, J., Ochoa, M. C., Ochoa-Callejero, L., Martnez, A., Luque, A., Dinchuk, J., Rouzaut, A., Jure-Kunkel, M., and Melero, I. (2011) Agonist anti-CD137 mAb act on tumor endothelial cells to enhance recruitment of activated T lymphocytes. Cancer Res. 71, 801-811
21. Drenkard, D., Becke, F., Langstein, J., Spruss, T., Kunz- Schughart, L., Tan, T., Lim, Y., and Schwarz, H. (2007) CD137 is expressed on blood vessel walls at sites of inflammation and enhances monocyte migratory activity. FASEB J. 21, 456-463 (Pubitemid 46213493)
22. Johnson, L., Clasper, S., Holt, A., Lalor, P., Baban, D., and Jackson, D. (2006) An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium. J. Exp. Med. 203, 2763-2777 (Pubitemid 44833351)
23. Vogel, J., West, G., Danese, S., De La Motte, C., Phillips, M., Strong, S., Willis, J., and Fiocchi, C. (2004) CD40-mediated immune-nonimmune cell interactions induce mucosal fibroblast chemokines leading to T-cell transmigration. Gastroenterology 126, 63-80 (Pubitemid 38040725)
24. Olofsson, P., Sderstrm, L., Wgster, D., Sheikine, Y., Ocaya, P., Lang, F., Rabu, C., Chen, L., Rudling, M., Aukrust, P., Hedin, U., Paulsson-Berne, G., Sirsj, A., and Hansson, G. (2008) CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice. Circulation 117, 1292-1301 (Pubitemid 351365671)
25. Jeon, H., Choi, J., Jung, I., Park, J., Lee, M., Lee, M., Kim, B., Yoo, J., Jeong, S., Kim, D., Park, J., Park, H., Kwack, K., Choi, B., Kwon, B., and Oh, G. (2010) CD137 (4-1BB) deficiency reduces atherosclerosis in hyperlipidemic mice. Circulation 121, 1124-1133
26. Johnson, L. A., and Jackson, D. G. (2008) Cell traffic and the lymphatic endothelium. Ann. N. Y. Acad. Sci. 1131, 119-133 (Pubitemid 351758509)
27. Pflicke, H., and Sixt, M. (2009) Preformed portals facilitate dendritic cell entry into afferent lymphatic vessels. J. Exp. Med. 206, 2925-2935
28. Johnson, L., and Jackson, D. (2010) Inflammation-induced secretion of CCL21 in lymphatic endothelium is a key regulator of integrin-mediated dendritic cell transmigration. Int. Immunol. 22, 839-849
29. Rabu, C., Qumner, A., Jacques, Y., Echasserieau, K., Vusio, P., and Lang, F. (2005) Production of recombinant human trimeric CD137L (4-1BBL). cross-linking is essential to its T cell costimulation activity. J. Biol. Chem. 280, 41472-41481 (Pubitemid 41832207)
30. Rouzaut, A., Garasa, S., Teijeira, A., Gonzlez, I., Martinez-Forero, I., Suarez, N., Larrea, E., Alfaro, C., Palazon, A., Dubrot, J., Hervs-Stubbs, S., and Melero, I. (2010) Dendritic cells adhere to and transmigrate across lymphatic endothelium in response to IFN-α. Eur. J. Immunol. 40, 3054-3063
31. Meyer, T. P. H., Zehnter, I., Hofmann, B., Zaisserer, J., Burkhart, J., Rapp, S., Weinauer, F., Schmitz, J., and Illert, W. E. (2005) Filter buffy coats (FBC): A source of peripheral blood leukocytes recovered from leukocyte depletion filters. J. Immunol. Meth. 307, 150-166 (Pubitemid 41817276)
32. Sallusto, F., and Lanzavecchia, A. (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179, 1109-1118
33. Clasper, S., Royston, D., Baban, D., Cao, Y., Ewers, S., Butz, S., Vestweber, D., and Jackson, D. (2008) A novel gene expression profile in lymphatics associated with tumor growth and nodal metastasis. Cancer Res. 68, 7293-7303
34. Irigoyen, M., Anso, E., Martinez, E., Garayoa, M., Martinez-Irujo, J. J., and Rouzaut, A. (2007) Hypoxia alters the adhesive properties of lymphatic endothelial cells. A transcriptional and functional study. Biochim. Biophys. Acta 1773, 880-890 (Pubitemid 46829434)
35. Wang, C., Lin, G. H. Y., McPherson, A., and Watts, T. (2009) Immune regulation by 4-1BB and 4-1BBL: Complexities and challenges. Immunol. Rev. 229, 192-215
36. Tal, O., Lim, H., Gurevich, I., Milo, I., Shipony, Z., Ng, L., Angeli, V., and Shakhar, G. (2011) DC mobilization from the skin requires docking to immobilized CCL21 on lymphatic endothelium and intralymphatic crawling. J. Exp. Med. 208, 2141-2153
37. McNamara, J., Kolonias, D., Pastor, F., Mittler, R., Chen, L., Giangrande, P., Sullenger, B., and Gilboa, E. (2008) Multivalent 4-1BB binding aptamers costimulate CD8 T cells and inhibit tumor growth in mice. J. Clin. Invest. 118, 376-386
38. Wilcox, R., Tamada, K., Flies, D., Zhu, G., Chapoval, A., Blazar, B., Kast, W. M., and Chen, L. (2004) Ligation of CD137 receptor prevents and reverses established anergy of CD8 cytolytic T lymphocytes in vivo. Blood 103, 177-184 (Pubitemid 38029936)
39. Nam, K., Kang, W., Kwon, B., Kim, S., and Lee, H. (2005) The therapeutic potential of 4-1BB (CD137) in cancer. Curr. Cancer Drug Targets 5, 357-363 (Pubitemid 41097759)
40. Tirapu, I., Arina, A., Mazzolini, G., Duarte, M., Alfaro, C., Feijoo, E., Qian, C., Chen, L., Prieto, J., and Melero, I. (2004) Improving efficacy of interleukin-12-transfected dendritic cells injected into murine colon cancer with anti-CD137 monoclonal antibodies and alloantigens. Int. J. Cancer 110, 51-60 (Pubitemid 38507203)
41. Niu, L., Strahotin, S., Hewes, B., Zhang, B., Zhang, Y., Archer, D., Spencer, T., Dillehay, D., Kwon, B., Chen, L., Vella, A., and Mittler, R. (2007) Cytokine-mediated disruption of lymphocyte trafficking, hemopoiesis, and induction of lymphopenia, anemia, and thrombocytopenia in anti-CD137-treated mice. J. Immunol. 178, 4194-4213 (Pubitemid 46492370)
42. Seaman, S., Stevens, J., Yang, M., Logsdon, D., Graff-Cherry, C., and St Croix, B. (2007) Genes that distinguish physiological and pathological angiogenesis. Cancer Cell 11, 539-554 (Pubitemid 46856908)
43. Angeli, V., and Randolph, G. (2006) Inflammation, lymphatic function, and dendritic cell migration. Lymphatic Res. Biol. 4, 217-228 (Pubitemid 46493659)
44. Saharinen, P., Tammela, T., Karkkainen, M., and Alitalo, K. (2004) Lymphatic vasculature: Development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol. 25, 387-395 (Pubitemid 38780956)
45. Steinman, R., Hawiger, D., and Nussenzweig, M. (2003) Tolerogenic dendritic cells. Ann. Rev. Immunol. 21, 685-711 (Pubitemid 37174545)
46. Alvarez, D., Vollmann, E., and von Andrian, U. (2008) Mechanisms and consequences of dendritic cell migration. Immunity 29, 325-342
47. Randolph, G. J. (2001) Dendritic cell migration to lymph nodes: cytokines, chemokines, and lipid mediators. Semin. Immunol. 13, 267-274
48. Schumann, K., Lmmermann, T., Bruckner, M., Legler, D., Polleux, J., Spatz, J., Schuler, G., Frster, R., Lutz, M., Sorokin, L., and Sixt, M. (2010) Immobilized chemokine fields and soluble chemokine gradients cooperatively shape migration patterns of dendritic cells. Immunity 32, 703-713
49. Melero, I., Hervas-Stubbs, S., Glennie, M., Pardoll, D., and Chen, L. (2007) Immunostimulatory monoclonal antibodies for cancer therapy. Nat. Rev. Cancer 7, 95-106 (Pubitemid 46160986)